333706866	333706866	CD	B-NP	O
|	|	NN	I-NP	O
DVBAC	DVBAC	NN	I-NP	O
|	|	NN	I-NP	O
29470645	29470645	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3638710	3638710	CD	B-NP	O
|	|	CC	I-NP	O
7/10/2006	7/10/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
substance	substance	NN	B-NP	O
abuse	abuse	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/22/2006	9/22/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/30/2006	7/30/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
DUMOND	DUMOND	NNP	B-NP	O
,	,	,	O	O
GUSTAVO	GUSTAVO	NNP	B-NP	O
R	R	NNP	I-NP	O
635-13-85-0	635-13-85-0	CD	I-NP	O
Woodlin	Woodlin	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
9/10/06	9/10/06	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
FUESS	FUESS	NNP	B-NP	O
,	,	,	O	O
RICHIE	RICHIE	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650	650	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
,	,	,	O	O
Headache	Headache	NNP	B-NP	O
AMOXICILLIN	AMOXICILLIN	NNP	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QID	QID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
May	May	MD	B-VP	O
be	be	VB	I-VP	O
taken	take	VBN	I-VP	O
without	without	IN	B-PP	O
regard	regard	NN	B-NP	O
to	to	TO	B-PP	O
meals	meal	NNS	B-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	VBD	B-VP	O
325	325	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/8/06	2/8/06	CD	B-NP	O
by	by	IN	B-PP	O
BOYLSTON	BOYLSTON	NNP	B-NP	O
,	,	,	O	O
ELLIOT	ELLIOT	NNP	B-NP	O
H	H	NNP	I-NP	O
A.	A.	NN	I-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
WARFARIN	WARFARIN	NN	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
PO	PO	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
322134973	322134973	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/8/06	2/8/06	CD	B-NP	O
by	by	IN	B-PP	O
SCHNITZ	SCHNITZ	NNP	B-NP	O
,	,	,	O	O
COLE	COLE	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
WARFARIN	WARFARIN	NN	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
259631942	259631942	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/8/06	2/8/06	CD	B-NP	O
by	by	IN	B-PP	O
BLASEN	BLASEN	NNP	B-NP	O
,	,	,	O	O
FREDDY	FREDDY	NNP	B-NP	O
L	L	NNP	I-NP	O
H.	H.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
WARFARIN	WARFARIN	NN	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
PO	PO	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
322134973	322134973	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/8/06	2/8/06	CD	B-NP	O
by	by	IN	B-PP	O
WIERSON	WIERSON	NNP	B-NP	O
,	,	,	O	O
BURTON	BURTON	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
WARFARIN	WARFARIN	NN	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
259631942	259631942	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/1/06	11/1/06	CD	B-NP	O
by	by	IN	B-PP	O
CHERVEN	CHERVEN	NNP	B-NP	O
,	,	,	O	O
JULIO	JULIO	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
MULTIVITAMIN	MULTIVITAMIN	NN	B-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
577759353	577759353	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
FOLATE	FOLATE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FOLIC	FOLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
11/1/06	11/1/06	CD	B-NP	O
by	by	IN	B-PP	O
MORDECAI	MORDECAI	NNP	B-NP	O
,	,	,	O	O
HARRY	HARRY	NNP	B-NP	O
V	V	NNP	I-NP	O
I.	I.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
K-DUR	K-DUR	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
639248310	639248310	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/1/06	11/1/06	CD	B-NP	O
by	by	IN	B-PP	O
GARACIA	GARACIA	NNP	B-NP	O
,	,	,	O	O
JOSE	JOSE	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ATIVAN	ATIVAN	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
LORAZEPAM	LORAZEPAM	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Anxiety	Anxiety	NNP	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
MULTIVITAMIN	MULTIVITAMIN	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
MULTIVI	MULTIVI	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/1/06	11/1/06	CD	B-NP	O
by	by	IN	B-PP	O
BRABOY	BRABOY	NNP	B-NP	O
,	,	,	O	O
CLIFTON	CLIFTON	NNP	B-NP	O
R	R	NNP	I-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	B-DNA
aware	aware	JJ	I-NP	I-DNA
THIAMINE	THIAMINE	NN	I-NP	I-DNA
HCL	HCL	NN	I-NP	I-DNA
100	100	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
WARFARIN	WARFARIN	NNP	I-NP	I-DNA
SODIUM	SODIUM	NNP	I-NP	I-DNA
10	10	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QPM	QPM	NNP	I-NP	I-DNA
Starting	Starting	NNP	I-NP	I-DNA
NOW	NOW	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
1/13	1/13	CD	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
Instructions	Instruction	NNPS	I-NP	I-DNA
:	:	:	O	O
WITHIN	WITHIN	NN	B-NP	O
HOUR	HOUR	NN	I-NP	O
OF	OF	IN	B-PP	O
PHARMACY	PHARMACY	NNP	B-NP	O
APPROVAL	APPROVAL	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/8/06	2/8/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/8/06	2/8/06	CD	B-NP	O
by	by	IN	B-PP	O
VOGLE	VOGLE	NNP	B-NP	O
,	,	,	O	O
CHONG	CHONG	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	B-NP	O
2	2	CD	I-NP	O
gm	gm	NN	I-NP	O
Na	Na	NN	I-NP	O
/	/	SYM	B-NP	O
Low	Low	NN	I-NP	O
saturated	saturate	VBD	B-VP	O
fat	fat	JJ	B-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Riebel	Riebel	NNP	I-NP	O
,	,	,	O	O
call	call	VBP	B-VP	O
184-142-9666	184-142-9666	CD	B-NP	O
8/24/06	8/24/06	CD	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
pm	pm	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
PO	PO	NN	B-NP	O
CONTRAST	CONTRAST	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
substance	substance	NN	B-NP	O
abuse	abuse	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
substance	substance	NN	B-NP	O
abuse	abuse	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
DC	DC	NNP	I-NP	B-cell_type
cardioversion	cardioversion	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
52M	52M	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
obesity	obesity	NN	B-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
USOH	USOH	NN	I-NP	B-protein
until	until	IN	B-PP	O
approx	approx	NN	B-NP	O
6-7	6-7	CD	B-NP	O
months	month	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
LEE	LEE	NN	I-NP	O
>	>	SYM	B-NP	O
on	on	IN	B-PP	O
L	L	NN	B-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
R	R	NN	B-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
last	last	JJ	B-NP	O
2	2	CD	I-NP	O
months	month	NNS	I-NP	O
he	he	PRP	B-NP	O
reports	report	VBZ	B-VP	O
developing	develop	VBG	I-VP	O
DOE	DOE	NNP	B-NP	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
progressed	progress	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
now	now	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
experiencing	experience	VBG	I-VP	O
SOB	SOB	NN	B-NP	B-protein
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
become	become	VBN	I-VP	O
acutely	acutely	RB	B-ADJP	O
worse	worse	RBR	I-ADJP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
lay	lay	VB	I-VP	O
flat	flat	JJ	B-ADJP	O
,	,	,	O	O
he	he	PRP	B-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
even	even	RB	B-ADVP	O
feels	feel	VBZ	B-VP	O
SOB	SOB	NN	B-NP	B-protein
when	when	WRB	B-ADVP	O
sitting	sit	VBG	B-VP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
sxs	sx	NNS	I-NP	O
are	be	VBP	B-VP	O
best	good	JJS	B-ADVP	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
standing	stand	VBG	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
arms	arm	NNS	I-NP	O
raised	raise	VBN	B-VP	O
above	above	IN	B-PP	O
his	his	PRP$	B-NP	O
head	head	NN	I-NP	O
.	.	.	O	O

Reports	Report	NNS	B-NP	O
PND	PND	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
and	and	CC	O	O
a	a	DT	B-NP	O
cough	cough	NN	I-NP	O
productive	productive	JJ	B-ADJP	O
of	of	IN	B-PP	O
white	white	JJ	B-NP	O
foam	foam	NN	I-NP	O
x	x	SYM	B-NP	O
2-3	2-3	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
bloating	bloat	VBG	I-VP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
abd	abd	NN	I-NP	O
girth	girth	NN	I-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
Arm	Arm	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
palpiatations	palpiatation	NNS	B-NP	O
,	,	,	O	O
n/v	n/v	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
melena	melena	NN	I-NP	O
,	,	,	O	O
BRBPR	BRBPR	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
calf	calf	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Has	Has	NNP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
loose	loose	JJ	I-NP	O
stool	stool	NN	I-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
amoxicillin	amoxicillin	NN	B-NP	B-protein
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
s/p	s/p	NN	B-NP	O
root	root	NN	I-NP	O
canal	canal	NN	I-NP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
and	and	CC	O	O
2.5	2.5	CD	B-NP	O
wks	wk	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
fever/chills	fever/chill	NNS	I-NP	O
.	.	.	O	O

IN	IN	IN	B-PP	O
ED	ED	NNP	B-NP	O
:	:	:	O	O
97.1	97.1	CD	B-NP	O
82183/100	82183/100	CD	I-NP	O
32	32	CD	I-NP	O
85-93	85-93	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
Received	Receive	VBD	B-VP	O
ASA	ASA	NNP	B-NP	O
325mg	325mg	NN	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
,	,	,	O	O
lopressor	lopressor	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
IV	IV	NN	I-NP	I-protein
,	,	,	O	O
morphine	morphine	NN	B-NP	O
4	4	CD	I-NP	O
,	,	,	O	O
KCL	KCL	NNP	B-NP	O
40	40	CD	I-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
,	,	,	I-NP	O
000uIV	000uIV	CD	I-NP	O
and	and	CC	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000u/hr	000u/hr	CD	I-NP	O
.	.	.	O	O

Then	Then	RB	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
nitro	nitro	NN	B-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
sinus	sinus	NN	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
to	to	TO	B-PP	O
140	140	CD	B-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
EKG	EKG	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
normal	normal	JJ	I-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
NSR	NSR	NN	B-NP	B-protein
,	,	,	O	O
LVH	LVH	NN	B-NP	B-protein
,	,	,	O	O
LAE	LAE	NN	B-NP	B-protein
,	,	,	O	O
TWI	TWI	NN	B-NP	O
in	in	IN	B-PP	O
V1	V1	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
new	new	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
STE	STE	NN	I-NP	O
in	in	IN	B-PP	O
v2	v2	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
old	old	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
and	and	CC	I-NP	O
V3	V3	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
new	new	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
strain	strain	NN	I-NP	O
pattern	pattern	NN	I-NP	O
,	,	,	O	O
q	q	NN	B-NP	O
waves	wave	NNS	I-NP	O
in	in	IN	B-PP	O
III	III	CD	B-NP	O
,	,	,	I-NP	O
II	II	CD	I-NP	O
,	,	,	I-NP	O
AVF	AVF	NN	I-NP	B-protein
.	.	.	O	O

*****	*****	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
Appy	Appy	JJ	B-ADJP	O
,	,	,	O	O
diverticulitis	diverticulitis	NN	B-NP	O
,	,	,	O	O
obesoty	obesoty	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
erythema	erythema	NN	B-NP	O
nodosum	nodosum	NN	I-NP	O
.	.	.	O	O

*************************************************	*************************************************	SYM	O	O
Meds	Med	NNPS	B-NP	O
:	:	:	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
QD	QD	NNP	I-NP	O
,	,	,	I-NP	O
Lisinopril	Lisinopril	NNP	I-NP	O
20	20	CD	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81mg	81mg	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
prilosec	prilosec	NN	B-NP	O
,	,	,	O	O
kdur	kdur	NN	B-NP	O
,	,	,	O	O
amoxicillin	amoxicillin	NN	B-NP	O
All	All	DT	B-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	B-protein
*************************************************	*************************************************	SYM	O	O
SocHx	SocHx	NN	B-NP	O
:	:	:	O	O
Car	Car	NN	B-NP	B-protein
salesman	salesman	NN	I-NP	O
.	.	.	O	O

Social	Social	JJ	B-NP	O
smoker	smoker	NN	I-NP	O
-	-	HYPH	O	O
2-3	2-3	CD	B-NP	O
cigs/wk	cigs/wk	NN	I-NP	O
-	-	HYPH	O	O
none	none	NN	B-NP	O
in	in	IN	B-PP	O
last	last	JJ	B-NP	B-protein
3	3	CD	I-NP	I-protein
yrs	yr	NNS	I-NP	I-protein
.	.	.	O	O

Drinks	Drink	VBZ	B-VP	O
1-2	1-2	CD	B-NP	O
drinks	drink	NNS	I-NP	O
every	every	DT	B-NP	O
other	other	JJ	I-NP	O
night	night	NN	I-NP	O
...	...	:	O	O
but	but	CC	O	O
notes	note	NNS	B-NP	O
suggest	suggest	VBP	B-VP	O
more	more	JJR	B-NP	O
ETOH	ETOH	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

FamHx	FamHx	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
Mother	Mother	DT	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
lymphoma	lymphoma	NN	B-NP	O
,	,	,	O	O
Father	Father	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
A.flutter	A.flutter	NN	I-NP	O
.	.	.	O	O

***********************************************	***********************************************	SYM	O	B-protein
Labs	Lab	NNPS	B-NP	I-protein
:	:	:	O	O
Cr	Cr	NN	B-NP	O
0.8	0.8	CD	I-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	O
8.95	8.95	CD	I-NP	O
,	,	,	O	O
Hct	Hct	NN	B-NP	O
43.6	43.6	CD	I-NP	O
CK	CK	NN	I-NP	O
143	143	CD	B-NP	O
,	,	,	O	O
CKMB	CKMB	NN	B-NP	B-protein
4.5	4.5	CD	I-NP	I-protein
,	,	,	O	O
Tn	Tn	NN	B-NP	B-protein
0.3	0.3	CD	I-NP	I-protein
CXR	CXR	NN	I-NP	I-protein
:	:	:	O	O
Cardiomegaly	Cardiomegaly	RB	B-ADVP	O
,	,	,	O	O
pulm	pulm	NN	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
?	?	.	O	O

L-sided	L-sided	JJ	B-NP	O
iniltrate	iniltrate	NN	I-NP	O
.	.	.	O	O

*****	*****	SYM	B-NP	O
STUDIES	STUDIES	NN	I-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
PET	PET	NN	I-NP	O
:	:	:	O	O
Final	Final	JJ	B-NP	O
impression	impression	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
PET-CT	PET-CT	NN	I-NP	O
test	test	NN	I-NP	O
results	result	NNS	I-NP	O
are	be	VBP	B-VP	O
abnormal	abnormal	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
following	following	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Mild	Mild	NNP	B-NP	O
calcified	calcify	VBD	B-VP	O
coronary	coronary	JJ	B-NP	O
plaque	plaque	NN	I-NP	O
burden	burden	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

A	A	DT	B-NP	O
medium	medium	NN	I-NP	O
size	size	NN	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
prior	prior	JJ	B-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
territory	territory	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
mild	mild	JJ	B-NP	O
residual	residual	JJ	I-NP	O
stress-induced	stress-induced	JJ	I-NP	O
peri-infarct	peri-infarct	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Severe	Severe	JJ	B-NP	O
LV	LV	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

ECHO	ECHO	NN	B-NP	O
:	:	:	O	O
Left	Left	NNP	B-NP	O
Ventricle	Ventricle	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
left	left	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
is	be	VBZ	B-VP	O
moderately	moderately	RB	I-VP	O
dilated	dilate	VBN	I-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
severe	severe	JJ	B-NP	O
concentric	concentric	JJ	I-NP	O
left	left	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
.	.	.	O	O

Overall	Overall	RB	B-ADVP	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
function	function	NN	I-NP	O
is	be	VBZ	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
estimated	estimate	VBN	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
is	be	VBZ	B-VP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
obvious	obvious	JJ	I-NP	O
akinetic	akinetic	JJ	I-NP	O
areas	area	NNS	I-NP	O
.	.	.	O	O

Right	Right	NNP	B-NP	O
Ventricle	Ventricle	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
right	right	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
well	well	RB	I-VP	O
seen	see	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
size	size	NN	I-NP	O
is	be	VBZ	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Global	Global	JJ	B-NP	O
right	right	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
is	be	VBZ	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Left	Left	NNP	B-NP	O
Atrium	Atrium	NNP	I-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
moderate	moderate	JJ	B-NP	O
left	left	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
enlargement	enlargement	NN	I-NP	O
.	.	.	O	O

Right	Right	NNP	B-NP	O
Atrium	Atrium	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
right	right	JJ	I-NP	O
atrium	atrium	NN	I-NP	O
is	be	VBZ	B-VP	O
mildly	mildly	RB	I-VP	O
dilated	dilate	VBN	I-VP	O
.	.	.	O	O

Aortic	Aortic	NNP	B-NP	O
Valve	Valve	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
aortic	aortic	JJ	I-NP	O
valve	valve	NN	I-NP	O
is	be	VBZ	B-VP	O
trileaflet	trileaflet	NN	B-NP	O
,	,	,	O	O
mildly	mildly	RB	B-VP	O
thickened	thicken	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
calcified	calcify	VBN	B-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
mildly	mildly	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
transaortic	transaortic	JJ	I-NP	O
gradients	gradient	NNS	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
aortic	aortic	JJ	B-NP	O
sclerosis	sclerosis	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
mild	mild	JJ	B-ADJP	O
to	to	TO	B-PP	O
moderate	moderate	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

Mitral	Mitral	NNP	B-NP	O
Valve	Valve	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
is	be	VBZ	B-VP	O
mildly	mildly	RB	I-VP	O
diffusely	diffusely	RB	I-VP	O
thickened	thicken	VBN	I-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
trace	trace	NN	B-NP	O
************************************************	************************************************	SYM	I-NP	O
A/P	A/P	NN	I-NP	O
:	:	:	O	O
52M	52M	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
SOB	SOB	NN	I-NP	O
,	,	,	O	O
LEE	LEE	NN	B-NP	B-protein
,	,	,	O	O
x	x	NN	B-NP	O
mos	mo	NNS	I-NP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
worsening	worsening	NN	I-NP	O
in	in	IN	B-PP	O
last	last	JJ	B-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
associated	associate	VBN	B-NP	O
troponin	troponin	NN	I-NP	O
leak	leak	NN	I-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
ISCHEMIA	ISCHEMIA	NN	I-NP	O
:	:	:	O	O
Small	Small	JJ	B-NP	O
troponin	troponin	NN	I-NP	O
leak	leak	NN	I-NP	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
-	-	HYPH	B-NP	O
demand	demand	NN	I-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
and	and	CC	I-NP	O
HTN	HTN	NN	I-NP	B-protein
.	.	.	O	O

ASA	ASA	NN	B-NP	O
325	325	CD	I-NP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
80	80	CD	I-NP	O
.	.	.	O	O

Elevated	Elevated	JJ	B-NP	O
LDL	LDL	NN	I-NP	O
113	113	CD	I-NP	O
.	.	.	O	O

homocysteine	homocysteine	NN	B-NP	O
WNL	WNL	NN	I-NP	O
,	,	,	O	O
hga1c	hga1c	NN	B-NP	O
elevated	elevate	VBN	B-VP	O
,	,	,	O	O
CRP	CRP	NN	B-NP	B-protein
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

Caridac	Caridac	NN	B-NP	O
PET	PET	NN	I-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
mild	mild	JJ	B-NP	O
calcified	calcify	VBN	I-NP	O
coronary	coronary	JJ	I-NP	O
plaque	plaque	NN	I-NP	O
burden	burden	NN	I-NP	O
,	,	,	O	O
med	me	VBN	B-NP	O
sized	sized	JJ	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
poor	poor	JJ	B-NP	O
perfusion	perfusion	NN	I-NP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
prior	prior	JJ	B-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
distal	distal	JJ	B-NP	O
LAD	LAD	NN	I-NP	O
territiory	territiory	NN	I-NP	O
.	.	.	O	O

LVEF	LVEF	NN	B-NP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
PUMP	PUMP	NN	I-NP	O
:	:	:	O	O
New	New	JJ	B-NP	O
CHF	CHF	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
ischemic	ischemic	JJ	I-NP	O
vs	v	NNS	I-NP	O
hypertrophic	hypertrophic	JJ	B-ADJP	O
vs	vs	IN	B-PP	O
alcoholic	alcoholic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
exacerbation	exacerbation	NN	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-VP	O
slow	slow	VB	I-VP	O
volume	volume	NN	B-NP	O
accumulations	accumulation	NNS	I-NP	O
-LRB-	-LRB-	JJ|NN	B-NP	O
NSAIDs	NSAID	NNS	I-NP	O
,	,	,	O	O
Amoxicillin	Amoxicillin	NNP	B-NP	O
,	,	,	O	O
dietary	dietary	JJ	B-NP	O
non-compliance	non-compliance	JJ	I-NP	O
-RRB-	-RRB-	SYM	O	O
-	-	HYPH	O	O
ECHO	ECHO	NN	B-NP	B-protein
shows	show	VBZ	B-VP	O
EF	EF	NN	B-NP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
cLVH	cLVH	NN	I-NP	O
,	,	,	O	O
AI	AI	NN	B-NP	O
.	.	.	O	O

Diuresed	Diurese	VBN	B-NP	O
approx	approx	NN	I-NP	O
10	10	CD	B-NP	O
liters	liter	NNS	I-NP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
lasix	lasix	NN	I-NP	O
.	.	.	O	O

Weight	Weight	RB	B-ADVP	O
from	from	IN	B-PP	O
155	155	CD	B-NP	O
kg	kg	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
admit	admit	VBP	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
to	to	TO	B-PP	O
149.5	149.5	CD	B-NP	O
kg	kg	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
discharge	discharge	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
40	40	CD	B-NP	O
QD	QD	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
RHYTHM	RHYTHM	NNP	I-NP	O
:	:	:	O	O
Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
and	and	CC	O	O
beta	beta	NN	B-NP	O
blockade	blockade	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
failed	fail	VBN	I-NP	O
DC	DC	NN	I-NP	O
cardioversion	cardioversion	NN	I-NP	O
.	.	.	O	O

Anticoagulated	Anticoagulate	VBN	B-VP	O
initially	initially	RB	B-ADVP	O
with	with	IN	B-PP	O
heparin	heparin	NN	B-NP	O
bridging	bridging	NN	I-NP	O
to	to	TO	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Heme/Anticoagulation	Heme/Anticoagulation	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
x	x	NN	I-NP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
1.1	1.1	CD	I-NP	O
and	and	CC	O	O
___	___	VBD	B-VP	O
prior	prior	RB	B-ADVP	O
the	the	DT	B-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
sent	send	VBD	B-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
lovenox	lovenox	NN	B-NP	O
bridge	bridge	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
at	at	IN	B-PP	O
AMC	AMC	NN	B-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
EtOHism	EtOHism	NN	I-NP	O
-	-	HYPH	B-NP	O
MVI/thiamine/folate	MVI/thiamine/folate	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
alcohol	alcohol	NN	B-NP	O
withdrawal	withdrawal	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Nutrition	Nutrition	NN	I-NP	O
-	-	HYPH	I-NP	O
2L	2L	NN	I-NP	O
fluid	fluid	NN	I-NP	O
restrict	restrict	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
sodium	sodium	NN	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
nutrition	nutrition	NN	B-NP	O
consulted/educated	consulted/educate	VBN	B-VP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Dental	Dental	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
-	-	HYPH	B-NP	O
prn	prn	JJ	I-NP	O
oxycodone	oxycodone	NN	I-NP	O
and	and	CC	I-NP	O
amoxicillin	amoxicillin	NN	I-NP	O
continued	continue	VBD	B-VP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
New	New	NNP	B-NP	O
Dose	Dose	NNP	I-NP	O
:	:	:	O	O
Furosemide	Furosemide	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Lasix	Lasix	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
Lisinopril	Lisinopril	NNP	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
*****	*****	SYM	I-NP	O
New	New	NNP	I-NP	O
Medications	Medication	NNPS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	B-protein
325	325	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
daily	daily	JJ	I-NP	I-protein
Toprol	Toprol	NN	I-NP	I-protein
XL	XL	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
metoprolol	metoprolol	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
100	100	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
daily	daily	JJ	I-NP	I-protein
Lipitor	Lipitor	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
atorvastatin	atorvastatin	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
warfarin	warfarin	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
Magnesium	Magnesium	NN	I-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
Potassium	Potassium	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
K-dur	K-dur	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
daily	daily	JJ	I-NP	O
Multivitamins	Multivitamin	NNS	I-NP	O
Thiamine	Thiamine	NN	I-NP	B-protein
100	100	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
daily	daily	JJ	I-NP	I-protein
Folate	Folate	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
daily	daily	JJ	I-NP	I-protein
*****	*****	SYM	I-NP	I-protein
Please	Please	NN	I-NP	I-protein
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
for	for	IN	B-PP	O
monitoring	monitoring	NN	B-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	I-NP	O
coumadin	coumadin	NN	I-NP	O
level	level	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
clinic	clinic	NN	I-NP	O
is	be	VBZ	B-VP	O
at	at	IN	B-PP	O
Ceya	Ceya	NNP	B-NP	O
St	St	NNP	I-NP	O
,	,	,	O	O
Flintco	Flintco	NNP	B-NP	O
Sa	Sa	NNP	I-NP	O
*****	*****	NNP	I-NP	O
Monitor	Monitor	NNP	I-NP	O
your	your	PRP$	B-NP	O
weight	weight	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
it	it	PRP	B-NP	O
increases	increase	VBZ	B-VP	O
by	by	IN	B-PP	O
3	3	CD	B-NP	O
pounds	pound	NNS	I-NP	O
,	,	,	O	O
then	then	RB	O	O
double	double	VB	B-VP	O
your	your	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Lobue	Lobue	NNP	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

f/u	f/u	NN	B-NP	O
INR	INR	NN	I-NP	O
with	with	IN	B-PP	O
goal	goal	NN	B-NP	O
2.0	2.0	CD	I-NP	O
to	to	TO	B-PP	O
3.0	3.0	CD	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

monitor	monitor	NN	B-NP	O
electrolytes	electrolyte	NNS	I-NP	O
as	as	IN	B-PP	O
pt	pt	NN	B-NP	O
being	be	VBG	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
diuretics	diuretic	NNS	B-NP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
ACEI	ACEI	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Monitor	Monitor	NN	B-NP	O
weight	weight	NN	I-NP	O
and	and	CC	I-NP	O
sodium/fluid	sodium/fluid	NN	I-NP	B-protein
restriction	restriction	NN	I-NP	I-protein
compliance	compliance	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Continue	Continue	NN	B-NP	O
to	to	TO	B-PP	O
stress	stress	NN	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
abstaining	abstain	VBG	B-VP	O
from	from	IN	B-PP	O
EtOH	EtOH	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
WHATCOTT	WHATCOTT	NNP	B-NP	O
,	,	,	O	O
ENRIQUE	ENRIQUE	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PE26	PE26	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
9/10/06	9/10/06	CD	I-NP	O
@	@	NN	I-NP	O
09	09	CD	I-NP	O
:	:	:	O	O
44	44	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

